51 – 60 of 171
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Opicapone versus placebo in the treatment of Parkinson’s disease patients with end-of-dose motor fluctuation-associated pain : rationale and design of the randomised, double-blind OCEAN (OpiCapone Effect on motor fluctuations and pAiN) trial
(
- Contribution to journal › Article
-
Mark
Pharmacokinetics of Intravenously (DIZ101), Subcutaneously (DIZ102), and Intestinally (LCIG) Infused Levodopa in Advanced Parkinson Disease
(
- Contribution to journal › Article
-
Mark
Comparative Effectiveness of Device-Aided Therapies on Quality of Life and Off-Time in Advanced Parkinson’s Disease : A Systematic Review and Bayesian Network Meta-analysis
(
- Contribution to journal › Scientific review
- 2021
-
Mark
Perspectives on Care for Late-Stage Parkinson's Disease
(
- Contribution to journal › Scientific review
-
Mark
Factors Associated with Health-Related Quality of Life in Late-Stage Parkinson's Disease
(
- Contribution to journal › Article
-
Mark
Longitudinal prediction of falls and near falls frequencies in Parkinson's disease:a prospective cohort study
(
- Contribution to journal › Article
-
Mark
The Long-Term Impact of Levodopa/Carbidopa Intestinal Gel on ‘Off’-time in Patients with Advanced Parkinson’s Disease : A Systematic Review
(
- Contribution to journal › Scientific review
-
Mark
Digital health technology for non-motor symptoms in people with Parkinson's disease : Futile or future?
(
- Contribution to journal › Scientific review
-
Mark
Parkinson’s disease in Sweden—resource use and costs by severity
(
- Contribution to journal › Article
-
Mark
Effects of safinamide on pain in patients with fluctuating Parkinson's disease
(
- Contribution to journal › Article